Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenyl Versus Pyridyl Substituents as Molecular Switches for Cellular Toxicity and Cellular Localization in Tetraarylvinylthiophenes.

Chemistry, an Asian journal·2026
Same author

π-Spacer effects in 2,6-disubstituted BODIPY fluorophores for mitochondrial imaging.

Organic & biomolecular chemistry·2026
Same author

Comparison of Analgesic Efficacy of Hyperbaric Levobupivacaine With or Without Clonidine in Patients Undergoing Intramedullary Nailing for Fracture Femur Under Subarachnoid Block: A Randomised Controlled Trial.

Cureus·2026
Same author

Vasorelaxation and antihypertensive activity of standardized extract of Gymnema sylvestre in rodent model.

Fitoterapia·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

DABCO-Catalyzed β-C(sp<sup>2</sup>)-H Indolylation of 4-Arylidene Pyrazolones and 5-Arylidene Thiazolones with <i>N</i>-Tosyliminoindoles.

The Journal of organic chemistry·2025
Same journal

Advancing Biochemical Molecule Registration, Representation and Search for New Drug Modalities.

Journal of chemical information and modeling·2026
Same journal

A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation.

Journal of chemical information and modeling·2026
Same journal

Intricate Role of Cholesterol in Membrane Fusion.

Journal of chemical information and modeling·2026
Same journal

tmGNN-XAI: An Explainable Graph Neural Network Tool for Predicting Electronic Properties of Transition Metal Complexes from SMILES.

Journal of chemical information and modeling·2026
Same journal

QSAR in the Browser: An Interactive Cheminformatics Web Application.

Journal of chemical information and modeling·2026
Same journal

FoldDoF: Utilizing the Primary Degrees of Freedom of Protein Backbone for Geometric Modeling and Generation.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

CAHNetF-DTP: A Community-Aware Heterogeneous Network-Based Embedding Framework for Drug-Target Interaction

Ashima Mittal1, Poonam Rani1, Ankush Jain1

  • 1CSE, Netaji Subhas University of Technology, Delhi, New Delhi 110078, India.

Journal of Chemical Information and Modeling
|May 11, 2026
PubMed
Summary
This summary is machine-generated.

We developed a novel framework, CAHNetF-DTP, for predicting drug-target interactions (DTIs). This community-aware heterogeneous network approach integrates diverse biological data, significantly improving DTI prediction accuracy in drug discovery.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: May 12, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Drug Discovery

Background:

  • Drug-target interactions (DTIs) are crucial for drug discovery, but experimental prediction is costly and time-consuming.
  • Existing network-based DTI prediction methods struggle to capture complex topological and biological relationships.
  • Identifying hidden patterns in drug-target networks is essential for efficient drug development.

Purpose of the Study:

  • To propose a novel computational framework, CAHNetF-DTP, for accurate drug-target interaction prediction.
  • To leverage a heterogeneous biomedical network and community-aware strategies for enhanced DTI prediction.
  • To address limitations in existing methods by capturing deeper biological and topological similarities.

Main Methods:

  • Developed CAHNetF-DTP, a community-aware heterogeneous network-based framework for DTI prediction.
  • Integrated 15 similarity-based subnetworks from drugs, targets, diseases, and side effects.
  • Utilized Word2Vec for entity embedding generation and a controlled negative sampling strategy for class imbalance.

Main Results:

  • CAHNetF-DTP demonstrated robust and competitive performance on benchmark datasets (KIBA, DAVIS) and real-world scenarios.
  • The proposed method outperformed most existing DTI prediction tools, including SAR-based approaches.
  • Case studies confirmed the model's capability in identifying novel drug-target pairs.

Conclusions:

  • Integrating heterogeneous biological data through a community-aware network framework significantly improves DTI prediction.
  • CAHNetF-DTP offers a valuable computational tool for accelerating drug discovery and identifying new therapeutic targets.
  • The framework's ability to capture complex relationships highlights the potential of advanced network analysis in bioinformatics.